MEDIA RELEASEInGeNA – Industry Genomics Network AllianceFOR IMMEDIATE RELEASE — Sydney, 24 September 2026 Ahead of a landmark October visit, including a National Press Club address in Canberra, InGeNA points to a pivotal moment for Australian genomics SYDNEY, 17...
Tuesday 6 October 2026 | 9.00 am to 10.30am AEDT | Online Australia is at a pivotal point in genomics and precision health — and the window to shape what comes next is open now. The forthcoming national health genomics policy framework and the Australian...
Turning clinical readiness into routine patient accessReflections from the Private Cancer Physicians of Australia Cancer Summit 2026 Private cancer physicians already see precision oncology as contemporary care. Systemic HTA reform is critical for Australia’s...
Australia is entering an important new phase for genomics and precision medicine, with growing momentum to move from research and individual programs towards clinical implementation and mainstream healthcare. InGeNA is delighted to host Dame Professor Sue Hill, Chief...
Professor Joanne Ngeow shared Singapore’s experience in building population genomics evidence and translating it into cancer prevention, clinical services and national reimbursement. Singapore’s National Precision Medicine Program began by sequencing 10,000 people,...
A Nature news feature has profiled a new wave of companies developing a different kind of gene therapy. Rather than cutting DNA, these therapies change the chemical markers that sit on it and switch genes on or off. The approach is called epigenetic editing. The...